Dario De Alcubierre

Pubblicazioni

Titolo Pubblicato in Anno
Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2024
Cardiac magnetic resonance reveals biventricular impairment in Cushing's syndrome: a multicentre case-control study ENDOCRINE 2024
Exploring sexual function in adrenal insufficiency: findings from the Dual RElease hydrocortisone versus conventionAl glucocorticoid replaceMent therapy in hypocortisolism (DREAM) trial ANDROLOGY 2024
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study PITUITARY 2024
New Approaches to the Treatment of Hypercortisolism. ANNUAL REVIEW OF MEDICINE 2024
Aggressive pituitary tumors and carcinomas: medical treatment beyond temozolomide. MINERVA ENDOCRINOLOGY 2024
BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study. EUROPEAN JOURNAL OF ENDOCRINOLOGY 2024
Polycystic Ovary Syndrome in the Context of Pituitary Adenomas: Prevalence, Pathophysiology and Clinical Management CLINICAL ENDOCRINOLOGY 2024
Impact of Female Sex and Mild Cortisol Secretion on Coagulation Profile in Adrenal Incidentalomas JOURNAL OF THE ENDOCRINE SOCIETY 2024
Pituitary adenoma consistency affects postoperative hormone function: a retrospective study BMC ENDOCRINE DISORDERS 2023
Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Inhibition of activin signalling reduces the growth of LβT2 gonadotroph pituitary tumours in mouse ENDOCRINE-RELATED CANCER 2023
Tall stature and gigantism in transition age: clinical and genetic aspects-a literature review and recommendations JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Effects of Dual-Release Hydrocortisone on Bone Metabolism in Primary and Secondary Adrenal Insufficiency: A 6-Year Study JOURNAL OF THE ENDOCRINE SOCIETY 2023
Clinical and Molecular Characteristics of Gonadotroph Pituitary Tumors According to the WHO Classification ENDOCRINE PATHOLOGY 2023
L’immunoterapia nel trattamento dei tumori ipofisari aggressivi. L'ENDOCRINOLOGO 2023
Therapeutic targeting of the pituitary tumor microenvironment. PHARMACOLOGY & THERAPEUTICS 2023
Effects of licorice on sex hormones and the reproductive system NUTRITION 2022
Coagulation parameters in asymptomatic patients with adrenal incidentaloma: is mild autonomous cortisol secretion correlated with thromboembolic risk? ENDOCRINE ABSTRACTS 2022
Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art CANCERS 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma